Get started
ATAI LIFE SCIENCES NVATAI LIFE SCIENCES NVATAI LIFE SCIENCES NV

ATAI LIFE SCIENCES NV

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ATAI/N chart


Full chart

Key facts today


ATAI Life Sciences N.V. reported positive Phase 2a trial results for BPL-003, showing lasting antidepressive effects for up to three months with no serious side effects in 12 patients.
Analyze the impactAnalyze the impact

ATAI/N upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.13 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−15.85 MXN
Net income (FY)
‪−3.11 B‬ MXN
Revenue (FY)
‪6.42 M‬ MXN
Shares float
‪134.40 M‬
Beta (1Y)
1.58

Employees


Employees (FY)
54
Change (1Y)
−29 −34.94%
Revenue / Employee (1Y)
‪118.92 K‬ MXN
Net income / Employee (1Y)
‪−57.63 M‬ MXN

About ATAI Life Sciences N.V.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Srinivas G. Rao
Website
atai.life
Headquarters
Berlin
Founded
2018
ISIN
NL0015000DX5
FIGI
BBG015LH5L68
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ATAI/N news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ATAI/N.

Frequently Asked Questions


The current price of ATAI/N is 35.00 MXN — it has decreased by −19.63% in the past 24 hours. Watch ATAI LIFE SCIENCES NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ATAI LIFE SCIENCES NV stocks are traded under the ticker ATAI/N.
We've gathered analysts' opinions on ATAI LIFE SCIENCES NV future price: according to them, ATAI/N price has a max estimate of 219.55 MXN and a min estimate of 99.79 MXN. Watch ATAI/N chart and read a more detailed ATAI LIFE SCIENCES NV stock forecast: see what analysts think of ATAI LIFE SCIENCES NV and suggest that you do with its stocks.
ATAI/N reached its all-time high on Mar 3, 2022 with the price of 113.07 MXN, and its all-time low was 22.90 MXN and was reached on Oct 31, 2024. View more price dynamics on ATAI/N chart.
See other stocks reaching their highest and lowest prices.
ATAI/N stock is 24.57% volatile and has beta coefficient of 1.58. Track ATAI LIFE SCIENCES NV stock price on the chart and check out the list of the most volatile stocks — is ATAI LIFE SCIENCES NV there?
Today ATAI LIFE SCIENCES NV has the market capitalization of ‪7.11 B‬, it has increased by 0.47% over the last week.
Yes, you can track ATAI LIFE SCIENCES NV financials in yearly and quarterly reports right on TradingView.
ATAI LIFE SCIENCES NV is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ATAI/N earnings for the last quarter are −3.07 MXN per share, whereas the estimation was −3.49 MXN resulting in a 12.07% surprise. The estimated earnings for the next quarter are −2.64 MXN per share. See more details about ATAI LIFE SCIENCES NV earnings.
ATAI LIFE SCIENCES NV revenue for the last quarter amounts to ‪31.86 M‬ MXN, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ATAI/N net income for the last quarter is ‪−541.50 M‬ MXN, while the quarter before that showed ‪−517.93 M‬ MXN of net income which accounts for −4.55% change. Track more ATAI LIFE SCIENCES NV financial stats to get the full picture.
No, ATAI/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2025, the company has 54 employees. See our rating of the largest employees — is ATAI LIFE SCIENCES NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATAI LIFE SCIENCES NV EBITDA is ‪−2.08 B‬ MXN, and current EBITDA margin is ‪−33.19 K‬%. See more stats in ATAI LIFE SCIENCES NV financial statements.
Like other stocks, ATAI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI LIFE SCIENCES NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI LIFE SCIENCES NV technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI LIFE SCIENCES NV stock shows the strong buy signal. See more of ATAI LIFE SCIENCES NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.